Stay updated on Sparsentan in IgA Nephropathy: Clinical Trial
Sign up to get notified when there's something new on the Sparsentan in IgA Nephropathy: Clinical Trial page.

Latest updates to the Sparsentan in IgA Nephropathy: Clinical Trial page
- Check4 days agoChange DetectedRecruitment status is updated to indicate no current participant enrollment, and the page adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study), updates the Intervention/Treatment header formatting, and includes a Revision: v3.6.0 note.SummaryDifference0.2%

- Check11 days agoChange DetectedA new Revision: v3.5.5 tag has been added, replacing the previous Revision: v3.5.4 tag. This indicates a minor version update to the page's template or documentation.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page's revision label was updated to Revision: v3.5.4, replacing the previous Revision: v3.5.3. This reflects deployment of a newer version of the page content and related resources.SummaryDifference0.0%

- Check54 days agoChange DetectedThe study page’s displayed update/version information has been refreshed, showing newer last update dates and an updated revision identifier. No substantive details about the clinical trial itself appear to be changed.SummaryDifference0.1%

- Check61 days agoChange DetectedAdded the 2026 Clin J Am Soc Nephrol publication by Heerspink et al. to the study's publications. Replaced the 2025 online-ahead-of-print reference with the final article and updated the revision to v3.5.2.SummaryDifference0.0%

- Check89 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0. This change does not affect study details or user-facing content.SummaryDifference0.0%

Stay in the know with updates to Sparsentan in IgA Nephropathy: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sparsentan in IgA Nephropathy: Clinical Trial page.